Acinetobacter baumannii with plasmids resisting antibiotic attacks

Decoding Antibiotic Resistance: How Acinetobacter Baumannii Plasmids Are Evolving

Rhea Morgan monogram
Rhea Morgan in Health & Wellness October 2026 • 4 min read.

"A Deep Dive into the Genetic Structures Enabling This Superbug to Defy Treatment"


In the relentless battle against infectious diseases, Acinetobacter baumannii stands out as a particularly formidable adversary. This Gram-negative bacterium, an opportunistic pathogen, is a key member of the ESKAPE group—a collection of microbes notorious for their ability to evade antibiotic treatments. The rise of A. baumannii is a global concern, driven primarily by its increasing resistance to multiple drugs.

Globally, most A. baumannii strains resistant to multiple antibiotics are categorized under two main groups: global clone 1 (GC1) and global clone 2 (GC2). These classifications help scientists track and understand the spread of resistance. Research has shown that GC1 strains evolved around 1960 and diversified into two distinct lineages by 1967. In contrast to other Gram-negative bacteria, A. baumannii often houses resistance genes within genomic resistance islands located on its chromosome.

Acinetobacter baumannii isolate D36, belonging to lineage 2 of global clone 1, exhibits extensive antibiotic resistance. A recent study examined four plasmids within D36, revealing how these genetic structures contribute to the bacterium's ability to withstand antibiotic treatments. The study sheds light on the genetic mechanisms that facilitate resistance, providing insights crucial for developing new strategies to combat this resilient pathogen.

AI Search Multiple angles on this topic

Antibiotics and Bacterial Infections

Antibiotics are antimicrobial substances active against bacteria and are widely used to treat and prevent bacterial infections. They may kill bacteria directly or inhibit their growth, reflecting the distinction between bactericidal and bacteriostatic medicines. The supplied sources do not provide statistics about Acinetobacter baumannii plasmids or their current impact.

The Antibiotic Era

Britannica describes an antibiotic as a chemical substance produced by a living organism that is detrimental to other microorganisms. The source reports that antibiotics came into worldwide prominence with the introduction of penicillin in 1941 and subsequently transformed the treatment of bacterial infections. It does not describe specific methods for studying Acinetobacter baumannii plasmids or the limitations of those methods.

Translation Tools, Not Antibiotic History

The supplied historical sources are translation services rather than records of antibiotic discoveries. Google Translate states that it translates words, phrases, and web pages between English and more than 100 languages, while QuillBot and DeepL describe Spanish-to-English translation capabilities. These sources do not substantiate historical milestones, foundational discoveries, or developments involving Acinetobacter baumannii plasmids.

What Makes D36 So Resistant?

Acinetobacter baumannii with plasmids resisting antibiotic attacks

The D36 genome comprises a chromosome and four plasmids, named pD36-1 through pD36-4, ranging in size from 4.7 to 47.2 kb. Among these, PRAY (pD36-2, 6 kb) and pD36-4 (47.4 kb) carry antibiotic resistance genes, while pD36-1 (4.7 kb) and pD36-3 (7.2 kb) are cryptic plasmids without known resistance functions. The copy numbers vary, with pD36-1, PRAY, and pD36-3 present in 11–13 copies per cell, while pD36-4 exists in only 2–3 copies.

The smallest plasmid, pD36-1, contains mobilization genes mobA and mobC, which are related to those in pRAY. PRAY carries the aadB gene cassette, providing resistance to gentamicin, kanamycin, and tobramycin. These plasmids lack identifiable replication initiation proteins, suggesting alternative replication mechanisms. Notably, PRAY can be mobilized by the large conjugative plasmid pA297-3, further aiding its spread.

  • pD36-1: Contains mobA and mobC, facilitating mobilization.
  • PRAY: Carries aadB, conferring resistance to gentamicin, kanamycin, and tobramycin. Mobilized by pA297-3.
  • pD36-3: A RepAcil plasmid with unique dif modules.
  • pD36-4: Includes sul2 (sulfonamide resistance) and aphA1a (kanamycin/neomycin resistance), plus a mer module for mercury resistance.
AI Search Multiple angles on this topic

No Plasmid Research Identified

The supplied sources do not contain research studies or reviews about Acinetobacter baumannii plasmids. They instead concern Microsoft Edge updates, Microsoft Support, Hotmail sign-in activity, and Windows 11 recovery procedures. Consequently, no evidence-based conclusion about the latest plasmid research can be drawn from this source set.

Evidence Limitations

Without sources specific to Acinetobacter baumannii plasmids, claims about competing interpretations, failed approaches, or research limitations remain uncertain. A balanced assessment would require studies that report methods, results, and disagreement directly. The available material is insufficient to identify a particular counterargument or failure.

Insufficient Comparative Evidence

The supplied material does not compare Acinetobacter baumannii plasmids with other plasmids, bacteria, or resistance mechanisms. Any comparison would therefore risk extending beyond the evidence provided. More directly relevant comparative sources would be needed to support a specific conclusion.

The largest plasmid, pD36-4, includes the sul2 gene for sulfonamide resistance and aphA1a within Tn4352::ISAba1, which confers resistance to kanamycin and neomycin. It also harbors a hybrid Tn501/Tn1696 transposon that confers resistance to mercuric ions, demonstrating a broad spectrum of resistance mechanisms. Further diversifying its defense arsenal, pD36-4 contains two novel Rep_3 family proteins, suggesting a co-integrate structure.

The Implications and Future Directions

Understanding the genetic structures within A. baumannii, such as plasmids like pD36-4 and pRAY, is crucial for devising effective countermeasures. As these plasmids can transfer resistance genes, limiting their spread is essential. Future research should focus on developing novel antimicrobial agents and strategies that circumvent these resistance mechanisms, ensuring effective treatment options remain available. Continuous monitoring and genetic analysis of A. baumannii strains will also aid in tracking the evolution of resistance and informing public health policies.

AI Search Multiple angles on this topic

Unrelated Product Listings

The supplied sources concern fuel tanks and replacement parts for the 2017 Nissan Rogue. NissanPartsDeal describes genuine 2017 Nissan Rogue US Make parts, AutoZone lists a 2017 Nissan Rogue fuel tank, and CARiD offers direct-fit fuel tanks and related components. These listings provide no expert commentary or evidence about antibiotic resistance or Acinetobacter baumannii plasmids.

Date Calculation Tools

The supplied future-oriented sources describe tools for calculating dates and elapsed time. Date Calculator, Time and Date, and GigaCalculator report functions such as finding differences between dates and adding or subtracting days, weeks, months, and years. They do not provide projections or research directions for Acinetobacter baumannii plasmids.

A Digital Workplace Example

The supplied source discusses Microsoft 365 Copilot and a LegalZoom agent operating inside Microsoft 365 Copilot. It presents this as a way to keep legal work within the user's workflow rather than addressing antibiotic resistance, healthcare systems, or plasmid transmission. No broader systemic conclusions about Acinetobacter baumannii can be supported from this source.

Evidence Needed

The available source material does not address patients, clinicians, caregivers, communities, or other human consequences of Acinetobacter baumannii plasmid evolution. Any discussion of lived experience or real-world impact would therefore be speculative. Relevant clinical and public-health sources would be needed for a grounded account.

What remains uncertain in the D36 findings

  • The authors said how lineage 2 acquired resistance to several antibiotics was not well understood.[1]
  • The proposed role of dif modules in plasmid evolution was an initial insight, not a complete account of how those modules move.[1]
  • The authors found close relatives of some modules in other plasmids, but not identical modules in GenBank, limiting direct sequence-to-sequence comparisons.[1]
  • The authors noted that a separate mobilization example could not be compared with pA297-3 because the conjugative plasmid’s sequence was unavailable.[1]

The material examined: D36 and its plasmids

PopulationAcinetobacter baumannii isolate D36 and plasmids found in it[2]
Sample sizeFour plasmids[2]
Times cited40[2]

Questions the D36 plasmids leave open

  • Which processes account for lineage 2 acquiring resistance to multiple antibiotics?[1]

Terms used to describe plasmid structure

pdif site
A site made of oppositely oriented XerC and XerD binding sites separated by six base pairs.[1]

Sources

  1. Genetic structure of four plasmids found in Acinetobacter baumannii isolate D36 belonging to lineage 2 of global clone 1 (Europe PMC, 2018)
  2. Genetic structure of four plasmids found in Acinetobacter baumannii isolate D36 belonging to lineage 2 of global clone 1 (Public Library of Science (PLoS), 2018)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1371/journal.pone.0204357, Alternate LINK

Title: Genetic Structure Of Four Plasmids Found In Acinetobacter Baumannii Isolate D36 Belonging To Lineage 2 Of Global Clone 1

Subject: Multidisciplinary

Journal: PLOS ONE

Publisher: Public Library of Science (PLoS)

Authors: Mohammad Hamidian, Ruth M. Hall

Published: 2018-09-27

Everything You Need To Know

1

What is Acinetobacter baumannii, and why is it a global concern?

Acinetobacter baumannii is a Gram-negative bacterium classified as an opportunistic pathogen and is a member of the ESKAPE group, known for its resistance to antibiotic treatments. Its increasing resistance to multiple drugs has made it a global concern, particularly the strains categorized under global clone 1 (GC1) and global clone 2 (GC2), which are frequently multi-drug resistant. The rise of multi-drug resistant strains like Acinetobacter baumannii poses a significant threat to healthcare globally because it limits treatment options and increases the risk of treatment failure for infections.

2

What are plasmids, and how do they contribute to the antibiotic resistance of Acinetobacter baumannii?

Plasmids are small, circular DNA molecules found in bacteria, separate from the main chromosome, and they often carry genes that provide bacteria with advantageous traits, such as antibiotic resistance. In Acinetobacter baumannii, plasmids like pD36-2 (PRAY*) and pD36-4 harbor antibiotic resistance genes. For example, PRAY* contains the aadB gene, which confers resistance to gentamicin, kanamycin, and tobramycin. The presence of these plasmids allows Acinetobacter baumannii to withstand the effects of antibiotics, thus making infections harder to treat.

3

Can you explain the difference between pD36-1, PRAY*, pD36-3, and pD36-4 plasmids found in Acinetobacter baumannii isolate D36?

The Acinetobacter baumannii isolate D36 contains four plasmids: pD36-1, PRAY* (pD36-2), pD36-3, and pD36-4. pD36-1 contains mobilization genes mobA and mobC, which facilitate its movement between bacterial cells. PRAY* carries the aadB gene, providing resistance to gentamicin, kanamycin, and tobramycin, and is mobilized by the plasmid pA297-3. pD36-3 is a RepAcil plasmid with unique dif modules, the function is still not fully explored. pD36-4 includes the sul2 gene for sulfonamide resistance and aphA1a gene, which provides resistance to kanamycin and neomycin. It also carries a mer module, providing resistance to mercuric ions. These plasmids, each with their unique set of genes, contribute to the overall antibiotic resistance profile of the bacterium.

4

How does the genetic makeup of pD36-4, specifically, contribute to the broad-spectrum resistance seen in Acinetobacter baumannii?

The pD36-4 plasmid is crucial in understanding the broad-spectrum resistance of Acinetobacter baumannii because it carries several resistance genes. Notably, it includes the sul2 gene, providing resistance to sulfonamides, and the aphA1a gene within Tn4352::ISAba1, conferring resistance to kanamycin and neomycin. Additionally, it contains a hybrid Tn501/Tn1696 transposon that confers resistance to mercuric ions. Furthermore, pD36-4 contains two novel Rep_3 family proteins, suggesting a co-integrate structure which might further diversify its defense mechanisms. The presence of these genes and structures allows Acinetobacter baumannii to resist a wide range of antibiotics and other toxic substances, making the bacterium very difficult to treat.

5

What are the implications of understanding the genetic structures, like plasmids, within Acinetobacter baumannii for the future of antibiotic treatment?

Understanding the genetic structures within Acinetobacter baumannii, particularly the plasmids such as pD36-4 and PRAY*, is critical for developing effective countermeasures against this superbug. Since these plasmids can transfer resistance genes, limiting their spread is essential. Future research must focus on novel antimicrobial agents and strategies that can circumvent these resistance mechanisms, ensuring effective treatment options remain available. Continuous monitoring and genetic analysis of Acinetobacter baumannii strains will help track the evolution of resistance. This information is vital for informing public health policies and developing targeted interventions. Essentially, detailed knowledge of the plasmids and their mechanisms enables scientists to stay ahead of the bacterium's evolving resistance capabilities.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.